Quincy Preston and Bella Pinera
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Dallas-based Sendero Consulting today announced the acquisition of Torq Consulting. Torq specializes in accelerating digital transformation through AI-powered custom development, data engineering and analytics.
The move adds about 90 consultants to Sendero’s roster....
Plano’s AnX Robotica, a provider of capsule-based gastrointestinal (GI) diagnostic solutions, recently launched NaviCONNECT, its next-generation cloud platform. The platform is engineered to support capsule endoscopy workflow, streamline practice management and improve connectivity for NaviCam products....
Dallas-based biopharmaceutical company Forte Biosciences Inc. has been acquired by Netherlands pharmaceutical company Argenx for $2.2 billion, the companies announced. Argenx CEO Karen Massey said in a statement that Forte’s experimental drug FB102 will add to the company’s ambition of being the “leading immunology innovator of the future.”...
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Dallas-based Sendero Consulting today announced the acquisition of Torq Consulting. Torq specializes in accelerating digital transformation through AI-powered custom development, data engineering and analytics.
The move adds about 90 consultants to Sendero’s roster....
Plano’s AnX Robotica, a provider of capsule-based gastrointestinal (GI) diagnostic solutions, recently launched NaviCONNECT, its next-generation cloud platform. The platform is engineered to support capsule endoscopy workflow, streamline practice management and improve connectivity for NaviCam products....
Dallas-based biopharmaceutical company Forte Biosciences Inc. has been acquired by Netherlands pharmaceutical company Argenx for $2.2 billion, the companies announced. Argenx CEO Karen Massey said in a statement that Forte’s experimental drug FB102 will add to the company’s ambition of being the “leading immunology innovator of the future.”...
